Literature DB >> 23343417

Cognitive insight in individuals at clinical high risk for psychosis.

David Kimhy1, Lauren Jobson-Ahmed, Shelly Ben-David, Lisa Ramadhar, Dolores Malaspina, Cheryl M Corcoran.   

Abstract

AIM: Reduced cognitive insight has been associated with psychotic symptoms, in particular with the presence of delusions; however, there is little information about whether such reductions are present in at-risk individuals prior to the onset of threshold psychotic symptoms.
METHOD: We conducted a cross-sectional comparison of cognitive insight (as indexed by the Beck Cognitive Insight Scale) in 62 help-seeking individuals at clinical high risk for psychosis, Fifty-nine individuals with schizophrenia-spectrum disorders and 37 healthy controls (HC). In patients, we evaluated associations of insight with positive symptoms, including later transition to psychosis in high-risk patients.
RESULTS: Individuals with schizophrenia reported significantly higher self-certainty scores than the at-risk patients and HCs, with the at-risk patients scoring intermediate to the individuals with schizophrenia and controls. Similarly, individuals with schizophrenia scored significantly higher on self-reflectiveness, with no differences between the at-risk patients and controls. In individuals with schizophrenia, delusions were significantly correlated with self-certainty. In at-risk patients, cognitive insight was not associated with positive symptom severity and did not differentiate those at-risk patients who later developed psychosis from those who did not. However, post hoc analyses suggested that at-risk patients with marked unusual thought content (approaching threshold psychosis) had lower self-reflectiveness; whereas those with high suspiciousness had significantly higher self-certainty.
CONCLUSIONS: The findings are discussed in the context of normal developmental processes occurring during adolescence, their putative links to neurobiological functioning, and their implications for treatment and future research.
© 2013 Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  delusions; insight; psychosis; psychosis prodrome; schizophrenia

Mesh:

Year:  2013        PMID: 23343417      PMCID: PMC3640765          DOI: 10.1111/eip.12023

Source DB:  PubMed          Journal:  Early Interv Psychiatry        ISSN: 1751-7885            Impact factor:   2.732


  30 in total

1.  Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability.

Authors:  Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

Review 2.  Assessment of cognitive insight: a qualitative review.

Authors:  Sally E Riggs; Paul M Grant; Dimitri Perivoliotis; Aaron T Beck
Journal:  Schizophr Bull       Date:  2010-08-06       Impact factor: 9.306

3.  Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk.

Authors:  Anthony P Morrison; Paul French; Sophie Parker; Morwenna Roberts; Helen Stevens; Richard P Bentall; Shôn W Lewis
Journal:  Schizophr Bull       Date:  2006-09-14       Impact factor: 9.306

4.  Measuring delusional ideation: the 21-item Peters et al. Delusions Inventory (PDI).

Authors:  Emmanuelle Peters; Stephen Joseph; Samantha Day; Philippa Garety
Journal:  Schizophr Bull       Date:  2004       Impact factor: 9.306

5.  Neural correlates of direct and reflected self-appraisals in adolescents and adults: when social perspective-taking informs self-perception.

Authors:  Jennifer H Pfeifer; Carrie L Masten; Larissa A Borofsky; Mirella Dapretto; Andrew J Fuligni; Matthew D Lieberman
Journal:  Child Dev       Date:  2009 Jul-Aug

6.  Symptomatic determinants of insight in schizophrenia spectrum disorders.

Authors:  Lisa Buchy; Ivan J Torres; Peter F Liddle; Todd S Woodward
Journal:  Compr Psychiatry       Date:  2009-03-10       Impact factor: 3.735

7.  Delusions in individuals with schizophrenia: factor structure, clinical correlates, and putative neurobiology.

Authors:  David Kimhy; Ray Goetz; Scott Yale; Cheryl Corcoran; Dolores Malaspina
Journal:  Psychopathology       Date:  2005-11-01       Impact factor: 1.944

8.  Use of Palm computer as an adjunct to cognitive-behavioural therapy with an ultra-high-risk patient: a case report.

Authors:  David Kimhy; Cheryl Corcoran
Journal:  Early Interv Psychiatry       Date:  2008-11       Impact factor: 2.732

9.  Negative v positive schizophrenia. Definition and validation.

Authors:  N C Andreasen; S Olsen
Journal:  Arch Gen Psychiatry       Date:  1982-07

10.  Delusions are associated with low self-reflectiveness in first-episode psychosis.

Authors:  L Buchy; A Malla; R Joober; M Lepage
Journal:  Schizophr Res       Date:  2009-04-15       Impact factor: 4.939

View more
  10 in total

Review 1.  Language as a biomarker for psychosis: A natural language processing approach.

Authors:  Cheryl M Corcoran; Vijay A Mittal; Carrie E Bearden; Raquel E Gur; Kasia Hitczenko; Zarina Bilgrami; Aleksandar Savic; Guillermo A Cecchi; Phillip Wolff
Journal:  Schizophr Res       Date:  2020-06-01       Impact factor: 4.939

2.  Medication adherence in first episode psychosis: the role of pre-onset subthreshold symptoms.

Authors:  J-G Daneault; A Maraj; M Lepage; A Malla; N Schmitz; S N Iyer; R Joober; J L Shah
Journal:  Acta Psychiatr Scand       Date:  2019-04       Impact factor: 6.392

3.  Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments.

Authors:  Paul H Lysaker; Michelle L Pattison; Bethany L Leonhardt; Scott Phelps; Jenifer L Vohs
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

4.  Relationships between self-reflectiveness and clinical symptoms in individuals during pre-morbid and early clinical stages of psychosis.

Authors:  Lihua Xu; Huiru Cui; Yanyan Wei; Zhenying Qian; Xiaochen Tang; Yegang Hu; Yingchan Wang; Hao Hu; Qian Guo; Yingying Tang; Tianhong Zhang; Jijun Wang
Journal:  Gen Psychiatr       Date:  2022-05-31

5.  Comorbid Personality Disorders in Individuals With an At-Risk Mental State for Psychosis: A Meta-Analytic Review.

Authors:  Tommaso Boldrini; Annalisa Tanzilli; Maria Pontillo; Antonio Chirumbolo; Stefano Vicari; Vittorio Lingiardi
Journal:  Front Psychiatry       Date:  2019-07-05       Impact factor: 4.157

6.  Co-occurring Deficits in Clinical and Cognitive Insight in Prolonged Schizophrenia-Spectrum Disorders: Relationship to Metacognitive Deficits.

Authors:  Joshua E Mervis; Kelsey A Bonfils; Samuel E Cooper; Courtney Wiesepape; Paul H Lysaker
Journal:  Schizophr Bull Open       Date:  2021-07-20

7.  Relationship Between Cognitive and Clinical Insight at Different Durations of Untreated Attenuated Psychotic Symptoms in High-Risk Individuals.

Authors:  LiHua Xu; Mei Zhang; ShuQin Wang; YanYan Wei; HuiRu Cui; ZhenYing Qian; YingChan Wang; XiaoChen Tang; YeGang Hu; YingYing Tang; TianHong Zhang; JiJun Wang
Journal:  Front Psychiatry       Date:  2021-11-10       Impact factor: 4.157

8.  Feasibility and efficacy of an acceptance and mindfulness-based group intervention for young people with early psychosis (Feel-Good group).

Authors:  Laura von Hardenberg; Karolina Leopold; Nikola Stenzel; Michèle Kallenbach; Navid Aliakbari; Andreas Bechdolf; Stephanie Mehl
Journal:  Front Psychiatry       Date:  2022-09-16       Impact factor: 5.435

9.  Correlations between exploratory eye movement, hallucination, and cortical gray matter volume in people with schizophrenia.

Authors:  Linlin Qiu; Hao Yan; Risheng Zhu; Jun Yan; Huishu Yuan; Yonghua Han; Weihua Yue; Lin Tian; Dai Zhang
Journal:  BMC Psychiatry       Date:  2018-07-13       Impact factor: 3.630

10.  E-Clinical High Risk for Psychosis: Viewpoint on Potential of Digital Innovations for Preventive Psychiatry.

Authors:  Paolo Fusar-Poli; Peter J Uhlhaas; Thomas Reilly; Andrea Mechelli; Philip McGuire
Journal:  JMIR Ment Health       Date:  2019-10-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.